Congressman Gus Bilirakis (R-FL) praised the U.S. Department of Health and Human Services’ decision to add Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy to the ...

The Portfolio returned 7.33% gross, significantly outperforming the MSCI World Health Care Index's 3.12% return. Click here ...

A group of pharma companies and Duchenne UK are collaborating to improve the chances of new treatments for Duchenne muscular dystrophy gaining NICE approval. Roche, Pfizer, PTC Therapeutics, and ...

Thursday, December 18, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA ...

Prince William and Kate Middleton made a subtle statement with their 2025 Christmas card. Keep reading for the details…MORE: ...

A report from analysts at Jefferies suggested that new screenings for metachromatic leukodystrophy and Duchenne muscular dystrophy could bump sales of the gene therapy Libmeldy by more than $100 ...

A fully integrated wheelchair drive-control platform, the ASL iON includes Bluetooth connectivity for up to eight devices, multiple active drive controls for the user to navigate through, ...

An 8-year-old boy made medical history thanks to Columbus doctors. Yet the city where it happened barely registered. Time we ...

Phase 2 results with Wave Life Sciences' Duchenne muscular dystrophy candidate WVE-N531 pushed the company's share price to its highest level in a year and could lead to discussions with regulators ...

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...

It has been among my greatest joys in Congress to help combat DMD and other muscular dystrophies. We have seen a direct relationship between increased research funding and longer lifespans for ...

U.S. health officials have added two deadly rare diseases to the list of conditions the government recommends states screen ...